Glaucoma Treatment Market - Overall Industry Analysis By Types, By Therapy and By End Users during forecast period 2017-2023

Market Scenario:

Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract. 

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2962

The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics. Older population has higher risk of developing glaucoma although other age groups may be affected. Other high risk groups include diabetics and those with a family history of glaucoma. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc.

The product development strategies have been very impressive with the surgery option. The last decade has seen impressive additions to the surgery options such as laser therapy, photodynamic therapy etc. The market constraints are excellent efficacy and efficiency of present drugs especially prostaglandin analogs and carbonic anhydrase inhibitors, which has set the bar for a new therapy extremely high and the loss of patent protection on the major drugs used to treat glaucoma.

Taking all factors into consideration, we expect the Asia Pacific glaucoma treatment market to reach around $ 888.94 million in 2023 from $576.0 million in 2017, by the end of the forecast period at a CAGR of ~ 7.5 %. While the glaucoma drug market will grow by a flat CAGR of 2.1% the glaucoma surgery market is poised for an explosive CAGR of 18.5 %.

Key Players for Asia-Pacific Glaucoma Treatment Market:

Some of the key players in this market are: Novartis AG, Pfizer Inc., Allergan, Merck & Co., Ocular Therapeutix Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC., Ellex, Quantel, Lumenis, and Lightmed among others.

Segments:

Asia-Pacific Glaucoma Treatment Market has been segmented on the basis of disease indication which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. On the basis of drug class; market is segmented into prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others. On the basis of surgery; market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end users; market is segmented into hospitals and home users.

Regional Analysis of Asia-Pacific Glaucoma Treatment Market:

The healthcare sector of Asia Pacific varies immensely by countries. However the Asia Pacific region has lower public sector expenditure and most treatments involve out of pocket expenditure. Further the eye care has been a neglected segment especially in the poor countries of Asia Pacific region. Japan and South Korea are the leading markets while China will be the fastest growing due to rising healthcare expenditure and faster economic growth. Also the presence of strong generics especially in nations like India will lead to volume growth of anti-glaucoma drugs. The surgery market however will see fastest growth in Japan as compared to developing parts of Asia Pacific.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2962

Detailed Table of Contents:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

List Of Tables

Table 1 Asia-Pacific Glaucoma Treatment Market, 2013-2022 (Usd Million)

Table 2 Asia-Pacific Glaucoma Treatment Market, By Disease Indication, 2013-2022 (Usd Million)

Table 3 Asia-Pacific Glaucoma Treatment Market, By Drug Class, 2013-2022 (Usd Million)

Table 4 Asia-Pacific Glaucoma Treatment Market, By Surgery, 2013-2022 (Usd Million)

Table 5 Asia-Pacific Glaucoma Treatment Market, By End Users, 2013-2022 (Usd Million)

Table 6 Asia-Pacific Glaucoma Treatment Market, By Region, 2013-2022 (Usd Million)

List Of Figures

Figure 1 Research Process

Figure 2 Porters Five Forces Model

Figure 3 Asia-Pacific Glaucoma Treatment Market, By Disease Indication

Figure 4 Asia-Pacific Glaucoma Treatment Market, By Drug Class

Figure 5 Asia-Pacific Glaucoma Treatment Market, By Surgery

Figure 6 Asia-Pacific Glaucoma Treatment Market, By End Users

Figure 7 Asia-Pacific Glaucoma Treatment Market, By Region

Figure 8 Asia-Pacific Glaucoma Treatment Market: Company Share Analysis, 2015 (%)

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/2962     

         

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com